TTM
27.6%
YoY change
+42.72pp
Trough year (2000)
-1225.3%
Peak year (2017)
44.9%
Latest annual
26.1%
EBITDA Margin history chart for Illumina (ILMN) from 2000 to 2025
Latest: 26.1%
EBITDA Margin change chart for Illumina (ILMN) from 2000 to 2025
Latest: +42.72pp
EBITDA Margin history table for Illumina (ILMN) from 2000 to 2025
| 2025 | 26.1% | +42.72pp | ||
| 2024 | -16.6% | -3.08pp | ||
| 2023 | -13.5% | +71.93pp | ||
| 2022 | -85.4% | -111.85pp | ||
| 2021 | 26.4% | -7.29pp | ||
| 2020 | 33.7% | -4.61pp | ||
| 2019 | 38.3% | +4.43pp | ||
| 2018 | 33.9% | -11.01pp | ||
| 2017 | 44.9% | +14.27pp | ||
| 2016 | 30.6% | -3.28pp | ||
| 2015 | 33.9% | +1.52pp | ||
| 2014 | 32.4% | +11.51pp | ||
| 2013 | 20.9% | -7.47pp | ||
| 2012 | 28.4% | +5.90pp | ||
| 2011 | 22.5% | -5.46pp | ||
| 2010 | 27.9% | +2.55pp | ||
| 2009 | 25.4% | +3.98pp | ||
| 2008 | 21.4% | +16.48pp | ||
| 2007 | 4.9% | -18.67pp | ||
| 2006 | 23.6% | +25.82pp | ||
| 2005 | -2.2% | -1.23pp | ||
| 2004 | -1.0% | +67.44pp | ||
| 2003 | -68.5% | +253.81pp | ||
| 2002 | -322.3% | +585.06pp | ||
| 2001 | -907.3% | +317.94pp | ||
| 2000 | -1225.3% | — |
- 202526.1%+42.72pp
- 2024-16.6%-3.08pp
- 2023-13.5%+71.93pp
- 2022-85.4%-111.85pp
- 202126.4%-7.29pp
- 202033.7%-4.61pp
- 201938.3%+4.43pp
- 201833.9%-11.01pp
- 201744.9%+14.27pp
- 201630.6%-3.28pp
- 201533.9%+1.52pp
- 201432.4%+11.51pp
- 201320.9%-7.47pp
- 201228.4%+5.90pp
- 201122.5%-5.46pp
- 201027.9%+2.55pp
- 200925.4%+3.98pp
- 200821.4%+16.48pp
- 20074.9%-18.67pp
- 200623.6%+25.82pp
- 2005-2.2%-1.23pp
- 2004-1.0%+67.44pp
- 2003-68.5%+253.81pp
- 2002-322.3%+585.06pp
- 2001-907.3%+317.94pp
- 2000-1225.3%—
EBITDA Margin values are taken from Illumina's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA Margin at Illumina (ILMN)
According to Illumina's latest reported financial statements, the company's latest reported EBITDA margin is 27.6%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Illumina (ILMN) reported EBITDA margin of 26.14% – expanded 42.7 percentage points year-over-year.
The highest annual EBITDA margin of 44.91% was reported in 2017. The lowest in the available history was -1225.26% in 2000.
Illumina EBITDA Margin by Year
Illumina EBITDA Margin 2025: 26.1%
Illumina EBITDA margin in 2025 was 26.14%, expanded 42.7 percentage points from 2024.
Illumina EBITDA Margin 2024: -16.6%
2024's EBITDA margin for Illumina came in at -16.58%, contracted 3.1 percentage points from 2023.
Illumina EBITDA Margin 2023: -13.5%
Illumina posted EBITDA margin of -13.50% in 2023, expanded 71.9 percentage points from 2022.
Illumina EBITDA Margin 2022: -85.4%
In 2022, Illumina reported EBITDA margin of -85.43%, contracted 111.9 percentage points from 2021.
Illumina EBITDA Margin 2021: 26.4%
Illumina EBITDA margin in 2021 was 26.43%.
See more financial history for Illumina (ILMN).
Sector peers by EBITDA Margin
Healthcare peers of Illumina (ILMN), ranked by their latest EBITDA margin
| 55.4% | |
| 46.6% | |
| 45.9% | |
| 34.6% | |
| 33.9% | |
| 30.3% | |
| 26.9% | |
| 5.1% |
- 55.4%
- 46.6%
- 45.9%
- 34.6%
- 33.9%
- 26.9%
Frequently asked questions
Illumina (ILMN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation